Cargando…
Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing
It has been suggested that chemoresistance of chondrosarcoma (CHS), the cartilage tumor, is caused by the phenotypic microenvironmental features of the tumor tissue, mainly the chondrogenic extracellular matrix (ECM), and hypoxia. We developed and characterized a multicellular tumor spheroid (MCTS)...
Autores principales: | Voissiere, Aurélien, Jouberton, Elodie, Maubert, Elise, Degoul, Françoise, Peyrode, Caroline, Chezal, Jean-Michel, Miot-Noirault, Élisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509331/ https://www.ncbi.nlm.nih.gov/pubmed/28704566 http://dx.doi.org/10.1371/journal.pone.0181340 |
Ejemplares similares
-
Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept
por: Voissiere, Aurélien, et al.
Publicado: (2017) -
A“Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model
por: Peyrode, Caroline, et al.
Publicado: (2011) -
(99m)Tc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model
por: Miot-Noirault, Elisabeth, et al.
Publicado: (2013) -
Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms()
por: Akil, Hussein, et al.
Publicado: (2019) -
[(18)F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer
por: Jouberton, Elodie, et al.
Publicado: (2020)